04/29/2024
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
04/26/2024
6:43 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
4:00 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:48 PM | Renalytix (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/09/2024
3:51 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:31 PM | Renalytix (Filer)
| Form 424B5 | |
04/08/2024
6:44 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/04/2024
9:15 AM | CVI Investments, Inc. (Filed by)
Renalytix (Subject)
| Form SC 13G | |
03/29/2024
4:05 PM | Renalytix (Filer)
| Form DEF 14A | |
03/21/2024
2:30 PM | JEFFERSON RIVER CAPITAL LLC (Filed by)
Renalytix (Subject)
| Form SC 13D/A | |
03/14/2024
6:15 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:37 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
5:05 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
6:15 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
6:15 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
7:02 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2023
4:00 PM | Renalytix (Filer)
| Form DEFA14A | |
11/22/2023
3:27 PM | Doran Howard JR (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:27 PM | MILLS CHRISTOPHER (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:28 PM | Parikh Chirag R. (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:28 PM | LEVANGIE DANIEL J (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:29 PM | Coste Catherine (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:15 PM | Renalytix (Filer)
| Form DEFR14A | |
11/13/2023
8:22 AM | Renalytix (Filer)
| Form DEF 14A | |
10/24/2023
7:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2023
7:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
10/09/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
10/09/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
10/05/2023
7:30 PM | Renalytix (Filer)
| Form 10-K/A | |
10/03/2023
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
8:42 PM | Renalytix (Filer)
| Form RW WD | |
10/02/2023
3:00 PM | Renalytix (Filer)
| Form RW | |
09/28/2023
6:31 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
5:49 AM | Renalytix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/28/2023
5:54 AM | Renalytix (Filer)
| Form POS AM | |
09/28/2023
5:55 AM | Renalytix (Filer)
| Form POS AM | |
09/28/2023
5:58 AM | Renalytix (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad) BREAKING - Pentagon to Spend $20 Billion on "Distributed AI"
The U.S. Space Force calls it a "game changer."
And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>> |
09/28/2023
5:18 AM | Renalytix (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/22/2023
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
3:15 PM | Doran Howard JR (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
6:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
4:16 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
3:49 PM | MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:24 PM | Renalytix (Issuer)
Sterling O. James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:25 PM | Fleming Fergus (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:26 PM | MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:27 PM | McCullough James Renwick (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:28 PM | Coste Catherine (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
3:29 PM | Donovan Michael J. (Reporting)
Renalytix (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:20 PM | LEVANGIE DANIEL J (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:21 PM | Lium Erik (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:21 PM | McCullough James Renwick (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:22 PM | MCLAIN THOMAS H (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:23 PM | MILLS CHRISTOPHER (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:23 PM | Parikh Chirag R. (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:24 PM | Renalytix (Issuer)
Scannell Timothy J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:24 PM | Renalytix (Issuer)
Sterling O. James (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:19 PM | Coste Catherine (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:19 PM | Donovan Michael J. (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
3:20 PM | Fleming Fergus (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
1:30 PM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
7:55 AM | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
MOUNT SINAI HEALTH SYSTEM, INC. (Reporting)
MOUNT SINAI HOSPITAL (Reporting)
MOUNT SINAI HOSPITALS GROUP, INC. (Reporting)
Renalytix (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2023
7:00 AM | Renalytix (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
6:00 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023
6:01 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2023
6:00 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/11/2023
4:02 PM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/11/2023
8:30 AM | Renalytix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
11:15 PM | Renalytix (Filer)
| Form EFFECT | |
